2024

1. A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain

   Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 24, Núm. 2, pp. 227-235

2. Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale

   Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 10, Núm. 2

3. Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population

   Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 16-22

4. Association of Serum Malondialdehyde Levels with Lipid Profile and Liver Function in Patients with Inflammatory Bowel Disease

   Antioxidants, Vol. 13, Núm. 10

5. Associations of serum sclerostin levels with body composition, pulmonary function, and exacerbations in COPD patients

   Pulmonology, Vol. 30, Núm. 6, pp. 512-521

6. Biomarkers in Alzheimer’s Disease: Are Olfactory Neuronal Precursors Useful for Antemortem Biomarker Research?

   Brain Sciences, Vol. 14, Núm. 1

7. Changes in AmotL2 Expression in Cells of the Human Enteral Nervous System in Oxaliplatin-Induced Enteric Neuropathy

   Biomedicines, Vol. 12, Núm. 9

8. Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: Discover study

   Multiple Sclerosis and Related Disorders, Vol. 90

9. Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes

   Nature Genetics, Vol. 56, Núm. 9, pp. 1878-1889

10. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023

    Neurologia, Vol. 39, Núm. 2, pp. 196-208

11. Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis

    Patient Preference and Adherence , Vol. 18, pp. 1163-1171

12. Dorsal root ganglion inflammation by oxaliplatin toxicity: DPEP1 as possible target for peripheral neuropathy prevention

    BMC Neuroscience, Vol. 25, Núm. 1

13. Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published data

    Journal of the European Academy of Dermatology and Venereology

14. Efficacy and safety of levosimendan in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: The LEVOCEST trial

    Catheterization and Cardiovascular Interventions

15. FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease

    International Journal of Molecular Sciences, Vol. 25, Núm. 10

16. GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study

    eClinicalMedicine, Vol. 74

17. Has the COVID-19 pandemic influenced the neurological development of children?

    Pediatria de Atencion Primaria, Vol. 26, Núm. 103, pp. 239-245

18. Home noninvasive ventilation in severe COPD: in whom does it work and how?

    ERJ Open Research, Vol. 10, Núm. 1

19. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

20. Impact of an integrated cardiology-intensive care medicine model on mortality in STEMI

    Revista Espanola de Cardiologia